Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease

Surgical Endoscopy

Volumn 25, Issue 6, 2011, Pages 1975-1984

  Bell, Reginald C W ^a   Freeman, Katherine D ^a  

^a SWEDISH MEDICAL CENTER   (United States)

Author keywords

Atypical symptoms; Cough; Esophyx; Laryngopharyngeal reflux; Refractory; TIF

Indexed keywords

STOMACH SECRETION INHIBITOR;

ACID ASPIRATION; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEARTBURN; HIATUS HERNIA; HUMAN; MALE; MEDIASTINUM DISEASE; OUTCOME ASSESSMENT; PATIENT SAFETY; PH MEASUREMENT; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; REOPERATION; RETROSPECTIVE STUDY; STOMACH FUNDOPLICATION; TOTAL QUALITY MANAGEMENT; TREATMENT FAILURE;

EID: 80051684110     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-010-1497-9     Document Type: Article

References (50)

1. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448-1456. (Pubitemid 27181367)
2. Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Modlin IM, Johnson SP, Allen J, Brill JV (2008) American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology 135:1383-1391, 1391.e1-e5.
3. Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, Haug K, de Groot G, van Oudvorst A, Dalvag A, Junghard O, Wiklund I (1998) Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 10:119-124. (Pubitemid 28101879)
4. Castell DO, Murray JA, Tutuian R, Orlando RC, Arnold R (2004) Review article: the pathophysiology of gastro-oesophageal reflux disease - oesophageal manifestations. Aliment Pharmacol Ther 20(Suppl 9):14-25. (Pubitemid 39657651)
5. Fass R (2007) Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure. Drugs 67:1521-1530. (Pubitemid 47267295)
6. Hunt RH, Yuan Y, Yaghoobi M (2007) GERD: new strategies and new failures. J Clin Gastroenterol 41(Suppl 2):S72-S80. (Pubitemid 46956114)
7. Swoger J, Ponsky J, Hicks DM, Richter JE, Abelson TI, Milstein C, Qadeer MA, Vaezi MF (2006) Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol 4:433- 441.
8. Vaezi MF, Richter JE, Stasney CR, Spiegel JR, Iannuzzi RA, Crawley JA, Hwang C, Sostek MB, Shaker R (2006) Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 116:254-260. (Pubitemid 44383934)
9. Hill LD, Kozarek RA, Kraemer SJ, Aye RW, Mercer CD, Low DE, Pope CE 2nd (1996) The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc 44:541-547. (Pubitemid 26386898)
10. Perry KA, Enestvedt CK, Lorenzo CS, Schipper P, Schindler J, Morris CD, Nason K, Luketich JD, Hunter JG, Jobe BA (2008) The integrity of esophagogastric junction anatomy in patients with isolated laryngopharyngeal reflux symptoms. J Gastrointest Surg 12:1880-1887.
11. Seltman AK, Kahrilas PJ, Chang EY, Mori M, Hunter JG, Jobe BA (2006) Endoscopic measurement of cardia circumference as an indicator of GERD. Gastrointest Endosc 63:22-31. (Pubitemid 41827772)
12. Hunter JG, Trus TL, Branum GD, Waring JP, Wood WC (1996) A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 223:673-685.
13. Sala E, Salminen P, Simberg S, Koskenvuo J, Ovaska J (2008) Laryngopharyngeal reflux disease treated with laparoscopic fundoplication. Dig Dis Sci 53:2397-2404.
14. Walker SJ, Holt S, Sanderson CJ, Stoddard CJ (1992) Comparison of Nissen total and Lind partial transabdominal fundoplication in the treatment of gastro-oesophgeal reflux. Br J Surg 79:410-414.
15. Westcott CJ, Hopkins MB, Bach K, Postma GN, Belafsky PC, Koufman JA (2004) Fundoplication for laryngopharyngeal reflux disease. J Am Coll Surg 199:23-30. (Pubitemid 38813290)
16. Lundell L (2004) Complications after anti-reflux surgery. Best Pract Res Clin Gastroenterol 18:935-945. (Pubitemid 39378180)
17. Cadiere GB, Buset M, Muls V, Rajan A, Rosch T, Eckardt AJ, Weerts J, Bastens B, Costamagna G, Marchese M, Louis H, Mana F, Sermon F, Gawlicka AK, Daniel MA, Deviere J (2008) Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg 32:1676-1688.
18. Cadiere GB, Van Sante N, Graves JE, Gawlicka AK, Rajan A (2009) Two-year results of a feasibility study on antireflux transoral incisionless fundoplication (TIF) using EsophyX. Surg Endosc 23:957-964.
19. Repici A, Fumagalli U, Malesci A, Barbera R, Gambaro C, Rosati R (2010) Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience. J Gastrointest Surg 14:1-6.
20. Testoni PA, Corsetti M, Di Pietro S, Castellaneta AG, Vailati C, Masci E, Passaretti S (2010) Effect of transoral incisionless fundoplication on symptoms, PPI use, and pH-impedance refluxes of GERD patients. World J Surg 34:750-757.
21. Hill LD, Kozarek RA (1999) The gastroesophageal flap valve. J Clin Gastroenterol 28:194-197.
22. Bell RC, Hanna P, Mills MR, Bowrey D (1999) Patterns of success and failure with laparoscopic Toupet fundoplication. Surg Endosc 13:1189-1194.
23. Belafsky PC, Postma GN, Koufman JA (2002) Validity and reliability of the reflux symptom index (RSI). J Voice 16(2): 274-279.
24. Velanovich V (2007) The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 20:130-134. (Pubitemid 46562851)
25. Bell RC, Cadiere GB (2010) Transoral esophago-gastric fundoplication: technical and safety considerations. Surg Endosc (accepted).
26. Demyttenaere SV, Bergman S, Pham T, Anderson J, Dettorre R, Melvin WS, Mikami DJ (2010) Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population. Surg Endosc 24:854-858.
27. Jobe BA, O'Rourke RW, McMahon BP, Gravesen F, Lorenzo C, Hunter JG, Bronner M, Kraemer SJ (2008) Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg 248: 69-76.
28. Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA (1996) Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183:217-224. (Pubitemid 26299184)
29. Tseng D, Rizvi AZ, Fennerty MB, Jobe BA, Diggs BS, Sheppard BC, Gross SC, Swanstrom LL, White NB, Aye RW, Hunter JG (2005) Forty-eight-hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure. J Gastrointest Surg 9:1043-1051.
30. Tutuian R, Castell DO (2006) Diagnostic procedures in GERD: principles and values of esophageal manometry and pH-monitoring. In: Granderath FA, Kamolz T, Pointner R (eds) Gastroesophageal reflux disease: principles of disease, diagnosis, and treatment. Springer-Verlag, New York, pp 121-138.
31. Pandolfino JE, Kwiatek MA (2008) Use and utility of the Bravo pH capsule. J Clin Gastroenterol 42:571-578.
32. Zerbib F, des Varannes SB, Roman S, Pouderoux P, Artigue F, Chaput U, Mion F, Caillol F, Verin E, Bommelaer G, Ducrotte P, Galmiche JP, Sifrim D (2005) Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 22:1011-1021. (Pubitemid 41634884)
33. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L (1999) Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45:172-180. (Pubitemid 29333764)
34. DeVault KR, Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100:190-200. (Pubitemid 41623288)
35. Bredenoord AJ, Dent J (2007) Proton pump inhibitor-therapy refractory gastro-oesophageal reflux disease patients, who are they? Gut 56:593-594. (Pubitemid 46580519)
36. Mainie I, Tutuian R, Agrawal A, Adams D, Castell DO (2006) Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 93:1483-1487. (Pubitemid 44893649)
37. Bredenoord AJ, Draaisma WA, Weusten BL, Gooszen HG, Smout AJ (2008) Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut 57:161-166. (Pubitemid 351158040)
38. Spechler SJ (2009) Surgery for gastroesophageal reflux disease: esophageal impedance to progress? Clin Gastroenterol Hepatol 7:1264-1265.
39. Jafri SM, Arora G, Triadafilopoulos G (2009) What is left of the endoscopic antireflux devices? Curr Opin Gastroenterol 25: 352-357.
40. Rothstein RI (2008) Endoscopic therapy of gastroesophageal reflux disease: outcomes of the randomized-controlled trials done to date. J Clin Gastroenterol 42:594-602. (Pubitemid 351572280)
41. Reavis KM, Melvin WS (2008) Advanced endoscopic technologies. Surg Endosc 22:1533-1546.
42. Pearl JP, Ponsky JL (2008) Natural orifice translumenal endoscopic surgery: a critical review. J Gastrointest Surg 12:1293- 1300.
43. Achem SR (2004) Acid inhibition in GERD-how much is enough? Am J Gastroenterol 99:997-999. (Pubitemid 38917799)
44. Milkes D, Gerson LB, Triadafilopoulos G (2004) Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD). Am J Gastroenterol 99: 991-996. (Pubitemid 38917798)
45. Portale G, Peters J, Hsieh CC, Tamhankar A, Arain M, Hagen J, Demeester S, Demeester T (2007) When are reflux episodes symptomatic? Dis Esophagus 20:47-52. (Pubitemid 46099875)
46. Grigolon A, Cantu P, Savojardo D, Conte D, Penagini R (2008) Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients. J Clin Gastroenterol 42:969-973.
47. Sweis R, Fox M, Anggiansah R, Anggiansah A, Basavaraju K, Canavan R, Wong T (2009) Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies. Aliment Pharmacol Ther 29:669-676.
48. von Renteln D, Schmidt D, Riecken B, Caca K (2010) Evaluating outcomes of endoscopic full-thickness plication for gastroesophageal reflux disease (GERD) with impedance monitoring. Surg Endosc 24:1040-1048.
49. SAGES (2009) SAGES Position Statement on Endoluminal Therapies for Gastrointestinal Diseases. Available at www.sages.org/publication/id/ENDOL Accessed 20 Oct 2010.
50. ASGS (2009) ASGS Position Statement on Natural Orifice Surgery and Transoral Incisionless Fundoplication. Available at www.theasgs.orgwww.sages. org/publication/id/ENDOL Accessed 20 Oct 2010.